School of Medicine
Showing 2,801-2,900 of 4,924 Results
-
Tarik F. Massoud, MD, PhD
Professor of Radiology (Neuroimaging and Neurointervention)
On Partial Leave from 08/12/2024 To 08/01/2025Current Research and Scholarly InterestsMy current interests are in molecular and translational imaging of the brain especially in neuro-oncology and cerebrovascular diseases, experimental aspects of neuroimaging, clinical neuroradiology, neuroradiological anatomy, and research education and academic training of radiologists and scientists.
-
Rustin Massoudi, MD
Clinical Assistant Professor, Urology
BioDr. Massoudi is a board certified urologist specializing in general urology and urologic oncology. He is a clinical assistant professor of urology at Stanford University School of Medicine. Dr. Massoudi has expertise in treating prostate cancer, kidney cancer, kidney stones, and enlarged prostate. He also cares for patients with bladder cancer, testicular cancer, urinary retention, and a wide range of other urologic conditions.
His experience encompasses the complete spectrum of treatment options. This includes advanced, minimally invasive techniques like endoscopy and laparoscopy, as well as robotic surgery, which can enable smaller incisions and potentially shorter recovery times. For cases where a minimally invasive approach isn’t feasible, he performs open surgery.
Dr. Massoudi partners with each patient and family to customize a treatment plan that fits their needs. He welcomes patients at all stages in their journey—from early to more advanced symptoms—and is dedicated to helping them manage their urologic health long-term. He values the rewards of helping patients through difficult times as they cope with urologic disorders.
Dr. Massoudi was drawn to urology for its unique combination of medical and surgical care, including the opportunity to use the most innovative techniques and technology. He enjoys establishing a rapport and staying in close communication with referring physicians. To ensure all of his patients receive comprehensive care, he collaborates with Stanford colleagues from endocrinology, nephrology, medical oncology, radiation oncology, and other specialties.
Building on his passion for biological sciences and bioengineering, Dr. Massoudi’s studies have included translational research into the use of proteomics to target proteins on the metabolic pathway of kidney cancer development. In partnership with the Stanford Kidney Cancer Research Program, he has also explored the role of the molecule IQGAP in kidney cancer cell migration, proliferation, differentiation, polarity, and adhesion.
While working at the Veterans Administration in Palo Alto, Dr. Massoudi collaborated on an investigation into the utility of nuclear imaging methods for identifying and staging bladder cancer. He also collaborated on research that used novel proteomic technology to understand the signaling mechanisms of renal cell carcinoma; he later performed in vitro experiments on novel biomarkers and therapeutic agents for treating it.
Dr. Massoudi has authored numerous articles on renal disorders, innovative treatment techniques and technologies, and related topics. His work has been featured in Cell, the Journal of Endourology, European Urology Oncology, Canadian Journal of Urology, American Journal of Medical Genetics, and others. He has made presentations at conferences including the American Urological Association, Society of Urology Oncology, and World Congress of Endourology.
Dr. Massoudi has received multiple honors for teaching, scholarship, and research including a Stanford Urology Teaching Award for Outstanding
Mentorship of Co-Residents. In addition, he won a Gold Humanism and Excellence in Teaching Award from Stanford University School of Medicine.
At the 43rd Annual Northern California Urological Society Conference, he won top honors for his presentation on IQGAP. -
Martha Meredith Masters
Clinical Assistant Professor, Emergency Medicine
BioM. Meredith Masters is currently the Marc and Laura Andreessen Medical Director for Disaster Relief for the Stanford University School of Medicine and a Clinical Assistant Professor in the Department of Emergency Medicine. In this role, she serves as the medical director for the Office of Emergency Management, providing clinical oversight to disaster planning and response across the Stanford Medicine platform.
Dr. Masters attended medical school at the Keck School of Medicine of USC, and trained with the Emergency Medicine Residency Program at the University of Wisconsin. Following residency, she completed the Emergency Medical Services and Disaster Medicine Fellowship with the Fire Department of New York.
Prior to joining the Emergency Medicine Faculty at Stanford, Dr. Masters served as the Medical Director for University Hospital EMS in Newark, NJ, and was part of the Emergency Medicine Faculty at Rutgers New Jersey Medical School.
Dr. Masters’ clinical and research interests are focused on disaster preparedness and mitigation, improving education in disaster medicine, and the ethical delivery of care during crises. -
Amy Li Matecki
Adjunct Clinical Instructor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Amy (Ying Li) Matecki has been licensed to practice medicine in California since 2002 and completed her Internal Medicine Residency as Chief Resident at Highland Hospital, Alameda Health System, a UCSF affiliate, in 2004. She received her degree in Acupuncture and Chinese medicine from ACCHS in 2009. She was a Faculty Attending Physician at Department of Medicine Residency at Highland Hospital from 2004 to 2019 and Chief of the Integrative Medicine Division from 2014 to 2019. She and her colleagues from allopathic medicine and Chinese Medicine created hospital privilege policy for licensed acupuncturists in 2011 and designed policies, procedures and training methods for acupuncturists to join the medical staff to provide inpatient acupuncture services at Highland Hospital. She helped to create the first Traditional Chinese Medicine (TCM) Residency from 2016 to 2019 at Alameda Health System Highland Hospital. Graduates from this residency program are able to work in allopathic academic teaching hospitals’ inpatient care and outpatient medical centers.
In addition to serving in the public hospital, Dr. Matecki joined Alta Bates Summit Medical Center (ABSMC) Comprehensive Cancer Center in 2004 where she started a community hospital-based acupuncture program to bridge Eastern and Western Medicine. She has been the Medical Director of Integrative Medicine at ABSMC since 2008. Integrating Chinese Medicine into conventional oncology practice, Dr. Matecki and her team not only provide clinical care but also present and publish their findings on safety from using acupuncture and integrative medicine to reduce the pain, nausea and anxiety that frequently accompanies conventional cancer treatments. In many case level observations, Dr. Matecki and her team note that the integration of Chinese Medicine may enhance cancer patients' quality of life.
Dr. Matecki was the principal investigator (PI) for acupuncture research for chronic post-chemotherapy fatigue in collaboration with Memorial Sloan-Kettering Cancer Center in New York. She presented her study on the safety of acupuncture for patients with lymphedema at the American Society of Clinical Oncology Breast Cancer Symposium in October 2009. She was co-investigator in a public hospital that studied acupuncture feasibility for Intensive Care Unit (ICU) patients which was published in the Journal of Alternative and Complementary Medicine (JACM) in 2017. She is the current PI for a Chinese herbal medicine research project at ABSMC. Following her team’s previous success at Highland hospital, she pioneered the first Sutter Bay Hospital Integrative Medicine TCM Residency training program at Alta Bates Summit Medical Center in 2023. https://vitals.sutterhealth.org/east-meets-west-health-system-launches-its-first-traditional-chinese-medicine-clinical-training-program/
Dr. Matecki is an Adjunct Clinical Faculty at Stanford Health Care, a member of the American Society of Clinical Oncology (ASCO), Society of Integrative Oncology (SIO); Fellow of the American College of Physicians (FACP); Co-founder of International Center for Integrative Medicine (ICIM); Board member of Society of Chinese American Physician Entrepreneurs (SCAPE); House delegate for California Medical Association (CMA). Matecki is currently serving on the State California Acupuncture Board, first appointed by Governor Jerry Brown in 2016, reappointed by Brown in 2017 and Governor Gavin Newsom in 2021. She served as the California Acupuncture Board President from 2017-2021 and the current board member. https://www.acupuncture.ca.gov/about_us/member_profiles.shtml#matecki . She continues to work on policy and safety guidelines for hospital-based Acupuncture and Integrative Medicine practice with a multidisciplinary team of physicians, nursing staff, acupuncturists and hospital administrators. -
Brittany Elizabeth Matheson, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioBrittany Matheson, PhD, is a clinical assistant professor and licensed clinical psychologist in the Eating Disorders Clinic. She completed her undergraduate degree at Duke University, doctorate from the Joint Doctoral Program in Clinical Psychology at San Diego State University and the University of California, San Diego, and APA clinical internship at Lucile Packard Children’s Hospital Stanford/Children’s Health Council. Dr. Matheson is a certified family-based treatment (FBT) therapist and consultant. She is also the director of the Stanford Eating Disorder Research Program Data Coordination Center and collaborates with colleagues on NIH-funded randomized clinical trials. Dr. Matheson's research interests include examining the psychosocial, neurocognitive, and familial factors related to disordered eating and excess weight gain in youth. She is interested in the development and implementation of evidence-based treatments for youth with disordered eating as well as better understanding factors that influence pediatric bariatric surgery outcomes. Dr. Matheson has specialized research and clinical expertise in the interplay among obesity, disordered eating, and autism spectrum disorder and is the attending psychologist for the LPCH metabolic and bariatric surgery program. She conducts comprehensive evaluations and provides evidence-based treatments for individuals across the age-spectrum with eating disorders, including anorexia nervosa, bulimia nervosa, binge eating disorder, avoidant/restrictive food intake disorder, and other specified feeding and eating disorders. Her recent research focuses on reducing access to care barriers by digitizing evidence-based treatments and utilizing technology to enhance treatment outcomes.
-
Gordon O. Matheson
Professor of Orthopaedic Surgery (Sports Medicine) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsSports Medicine, Musculoskeletal Injuries, Rehabilitation, Exercise Medicine, Prevention of Chronic Disease, Human-Centered Design, Conflict of interest in healthcare
-
Maya Mathur
Associate Professor (Research) of Pediatrics, of Medicine (Biomedical Informatics) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsSynthesizing evidence across studies while accounting for biases
-
AC Matin
Member, Cardiovascular Institute
Current Research and Scholarly Interests1. Improvement of our newly discovered cancer prodrug regimen that permits noninvaisve visualization of drug activation. 2. Tracking tumors & cancer metastases using bacterial magnetite and newly developed single-cell tracking by MRI. 3. Molecular basis of bacterial planktonic and biofilm antibiotic resistance on Earth and under space microgravity -- development of new countermeasures; 4. Bioremediation.
-
Ryan Matlow
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioRyan Matlow, Ph.D., is a child clinical psychologist who serves as Director of Community Programs for Stanford’s Early Life Stress and Resilience Program, and is a faculty member in Stanford's Human Rights and Trauma Mental Health Program. His clinical and research efforts focus on understanding and addressing the impact of stress, adversity, and trauma in children, families, and communities. In particular, Dr. Matlow seeks to apply current scientific knowledge of the neurobiological and developmental impact of stress, trauma, and adversity in shaping interventions and systems of care. Dr. Matlow is focused on engaging diverse populations and providing evidence-based individual, family, and systems interventions for posttraumatic stress following interpersonal trauma, with an emphasis on efforts in school, community, and integrated care settings. He is engaged in clinical service, program development, and interdisciplinary collaboration efforts that address childhood trauma exposure in communities that have been historically marginalized, under-resourced, and/or experienced human rights violations. He has worked extensively in providing trauma-focused psychological evaluation, treatment, and advocacy services with immigrant youth and families, with a focus on immigrants from Latin American countries. Dr. Matlow is involved in the training and dissemination of Stanford's Cue Centered Therapy (Carrion, 2015), a flexible, manualized intervention addressing childhood experiences of chronic trauma.
-
Magdalena Matusiak
Instructor, Pathology
Current Research and Scholarly InterestsMy research focuses on revealing clinically relevant prognostic markers associated with myeloid cell biology in solid malignancies. I currently. lead two main projects: first, using single-cell RNA Sequencing and bulk tissue genomics to discover tumor-associated macrophage (TAM) diversity and establish their prognostic and predictive markers, second: using multiplex tissue imaging (MIBI) to unravel prognostic markers of spatial heterogeneity in the colon cancer.
-
Harley H McAdams
Professor (Research) of Developmental Biology, Emeritus
Current Research and Scholarly InterestsExperimental and theoretical analysis and modeling of genetic regulatory circuits, particularly bacterial regulation and with emphasis on global regulation of Caulobacter crescentus. Bioinformatic analysis of bacterial genomes, global patterns of gene transcription and translation.
-
Tim McAdams, MD
Clinical Professor, Orthopaedic Surgery
Current Research and Scholarly InterestsCurrent studies include sports injuries in the NFL Athlete, evaluation of the graft types in the ACL injured knee, throwing athlete's shoulder, reconstruction techniques for elbow MCL injury, articular cartilage defects in the athlete's knee.
-
Katherine Rachel McCallie
Clinical Professor, Pediatrics - Neonatal and Developmental Medicine
Current Research and Scholarly InterestsLeveraging electronic health record (Epic) for improvement in NICU outcomes
Quality improvement in the NICU
Nutrition & growth in premature infants -
Emily Clair McClung, MD, FACOG
Clinical Assistant Professor, Obstetrics & Gynecology - Gynecologic Oncology
BioDr. McClung is a fellowship trained, board certified Gynecologic Oncologist with the Stanford Medicine Cancer Center and Clinical Assistant Professor in the Stanford Medicine Department of Obstetrics and Gynecology, Division of Gynecologic Oncology.
She graduated from the Icahn School of Medicine at Mount Sinai in New York City and she completed residency in Obstetrics and Gynecology at Stanford Medicine. She then pursued sub-specialty Gynecologic Oncology fellowship at Moffitt Cancer Center and the University of South Florida in Tampa, Florida.
Prior to joining Stanford Health Care, Dr. McClung was an Assistant Professor in the Department of Obstetrics and Gynecology at the University of Arizona Banner University Medical Center in Tucson, Arizona.
Dr. McClung actively contributes to gynecologic cancer research. She has studied prevention of surgical site infections, gene expression prediction of lymph node metastasis in endometrial cancer, treatment resistance in ovarian cancer, and additional topics. She co-authored articles on her findings for peer-reviewed publications such as the International Journal of Gynecologic Cancer, International Journal of Women’s Health, and Gynecologic Oncology Reports.
She authored the chapter on the diagnosis and management of vaginal cancer in the textbook Handbook of Gynecology and has made invited presentations at meetings of the Society of Gynecologic Oncology and other associations. She works to improve patient access to state-of-the-art care as an investigator in cooperative group clinical trials.
She has won multiple teaching awards for her work with medical students and residents. She is passionate about increasing awareness of gynecologic cancer in medical trainees.
Dr. McClung provides comprehensive care with a personalized approach for patients with gynecologic cancer and pre-cancer including surgery, chemotherapy, cancer risk reduction, and palliative care. She has a strong clinical interest in patient safety and quality of life both during and after cancer treatment. -
Michael V. McConnell, MD, MSEE
Clinical Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsMy imaging research has involved clinical and molecular Imaging of cardiovascular disease, with a focus on coronary and vascular diseases, including atherosclerosis, aortic aneurysms, and vascular inflammation.
My prevention research has involved innovative technologies to reduce coronary and vascular disease, including early disease detection plus leveraging mobile health and AI to enhance heart heart in patients and populations. -
Jamie McDonald, MD, MS
Clinical Assistant Professor, Neurology & Neurological Sciences
BioDr. McDonald is a fellowship-trained, board-certified neurologist and clinical assistant professor in the Department of Neurology at Stanford University School of Medicine.
She specializes in the diagnosis and treatment of multiple sclerosis and other demyelinating diseases, including neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein antibody disease (MOGAD). Dr. McDonald also provides comprehensive care to general neurology patients.
Dr. McDonald completed her internship and adult neurology residency at the University of Utah. She has a long-standing interest in multiple sclerosis care and went on to complete a two-year clinical MS/neuroimmunology fellowship at Stanford Health Care Multiple Sclerosis Center. Dr. McDonald received the National MS Society’s Sylvia Lawry Physician Fellowship, including formalized training in conducting clinical trials. As part of her fellowship, she completed a master’s degree in epidemiology and clinical research. -
Sean McGhee
Clinical Associate Professor, Pediatrics - Immunology and Allergy
Current Research and Scholarly InterestsBioinformatics
-
LAWRENCE McGLYNN
Clinical Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
Current Research and Scholarly InterestsMethamphetamine Abuse
HIV Neuropsychiatry -
Mark McGovern
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
BioDr. Mark McGovern is a Professor and the Associate Chair of Translation and Implementation Research in the Department of Psychiatry & Behavioral Sciences and, by courtesy, the Department of Medicine at Stanford University School of Medicine.
Most people who need health care do not receive it. And of those who do, wide variation exists in access to care and the quality of the care they receive in health care systems, both private and public. Dr. McGovern is a leader in using rigorous methods of implementation science to close these gaps in health care delivery.
His mission is to get the best health care possible to the people who need it the most.
Dr. McGovern's primary focus is the implementation and sustainment of evidence-based interventions and guideline adherent care in public and private health care systems and organizations. Within the hub of the Stanford Center for Dissemination and Implementation (CDI) which he directs, Dr. McGovern is the Principal Investigator (PI) and leads three national implementation research and practice centers: The Center for Dissemination and Implementation At Stanford (C-DIAS); The Research Adoption Support Center (RASC); and, the Mental Health Technology Transfer Center Network Coordinating Center (MHTTC). The 3 centers are federally-funded, respectively by the National Institute on Drug Abuse (P50DA05402), the National Institutes of Health Healing Addiction Long Term (HEAL) initiative (U2CDA057717), and the US Department of Health and Human Services Substance Use and Mental Health Services Administration (H79SM081726). Dr. McGovern is also the PI on a multi-site adaptive implementation trial across a state system of care, which aims to integrate addiction medications for persons with opioid use disorder who are receiving services in specialty or primary care organizations (R01DA052975). In addition, he addresses implementation challenges in federally-qualified health centers (FQHCs) across the State of California, in the Stanford Division of Primary Care and Population Health, and in specialty addiction and mental health treatment organizations nationwide. He leads, facilitates and/or actively engages networks advancing implementation science in health, including the NIDA Clinical Trials Network Translation & Implementation Special Interest Group, the NIDA Clinical Trials Western States Node Translation & Implementation Workgroup, the Stanford University Network for Dissemination & Implementation Research (SUNDIR), the VA Palo Alto HSR&D Center for Innovation to Implementation, and the Stanford Medicine Center for Improvement. He is on the Core Faculty of the National Institute of Mental Health Implementation Research Institute at the Washington University in St. Louis. Dr. McGovern is a collaborator on multiple projects as a co-investigator, consultant, or advisory board member. He is a mentor to numerous individuals across the country and at Stanford, from university undergraduates to mid-career faculty and clinical administrators at academic institutions and health care systems nationwide. -
Steven Lee Mcintire
Clinical Associate Professor, Neurology & Neurological Sciences
BioDr. McIntire earned his MD from Harvard Medical School and his PhD in Neuroscience from Harvard University, where he was awarded a Frank Knox Memorial Fellowship and Carl Walter Fellowship. He then completed Neurology residency training at UCSF. He is board certified in Neurology by the American Board of Psychiatry and Neurology. He has been named a Robert Ebert Clinical Scholar and Culpepper Medical Science Scholar. Dr. McIntire has published extensively in the fields of molecular neurobiology and neurogenetics.
Dr. McIntire’s interests are in general/comprehensive neurology. He is also interested in medical education and the training of medical students and neurology residents. -
David B. McKay
Professor of Structural Biology, Emeritus
Current Research and Scholarly InterestsThree-dimensional structure determination and biophysical studies of macromolecules.
-
Rebecca Mckenzie
Clinical Assistant Professor, Pediatrics - General Pediatrics
Current Research and Scholarly InterestsPediatric liver transplant, outcomes, adherence, transition, liver failure
-
Safyer McKenzie-Sampson
Instructor, Pediatrics - Neonatal and Developmental Medicine
BioSafyer McKenzie-Sampson is an IDEAL Provostial Fellow and instructor within the Department of Pediatrics at Stanford University. Dr. McKenzie-Sampson is a social and perinatal epidemiologist, focused on researching the multi-level impacts of exposure to racism across the life course on the risk of adverse perinatal outcomes in Black communities, with the goal of translating findings into interventions to increase birth justice. Her research portfolio uniquely interrogates the rates of adverse perinatal outcomes through the lens of maternal nativity in the United States which allows for focus on the experiences of Black immigrants. She is currently the principal investigator of the AZANIA study, a mixed methods pilot study which collects data on the pregnancy and childbirth experiences of African immigrants in California. Dr. McKenzie-Sampson received her PhD in Epidemiology and Translational Science from the University of California San Francisco, and in addition to her research, she supports families in the Bay Area as a full-spectrum community doula.
-
Tracey McLaughlin
Professor of Medicine (Endocrinology)
Current Research and Scholarly InterestsDr. McLaughlin conducts clinical research related to obesity, insulin resistance, diabetes, and cardiovascular disease (CVD). Current studies include: 1) the impact of macronutrient composition on metabolism, DM2 and CVD; 2) comparison of different weight loss diets on metabolism and CVD risk reduction ; 3) role of adipocytes and adipose tissue immune cells in modulating insulin resistance; 4) use of continuous glucose monitoring and multi-omics to define metabolic phenotype and precision diets
-
Uel Jackson McMahan
Professor of Neurobiology and of Structural Biology, Emeritus
Current Research and Scholarly InterestsWe are currently investigating mechanisms involved in synaptic transmission and synaptogenesis using electron microscope tomography in ways that provide in situ 3D structural information at macromolecular resolution.
-
Jennifer A McNab
Associate Professor (Research) of Radiology (Radiological Sciences Laboratory)
Current Research and Scholarly InterestsMy research is focused on developing magnetic resonance imaging (MRI) methods that probe brain tissue microstructure. This requires new MRI contrast mechanisms, strategic encoding and reconstruction schemes, physiological monitoring, brain tissue modeling and validation. Applications of these methods include neuronavigation, neurosurgical planning and the development of improved biomarkers for brain development, degeneration, disease and injury.
-
Kimford Meador, MD
Professor of Neurology and Neurological Sciences (Adult Neurology)
BioDr. Meador is a Professor of Neurology and Neurosciences at Stanford University, and Clinical Director, Stanford Comprehensive Epilepsy Center. Dr. Meador graduated from the Georgia Institute of Technology in Applied Biology (with high honor) and received his MD from the Medical College of Georgia. After an internship at the University of Virginia and service as an officer in the Public Health Corps, he completed a residency in Neurology at the Medical College of Georgia and a fellowship in Behavioral Neurology at the University of Florida. Dr. Meador joined the faculty at the Medical College of Georgia (1984-2002) where he became the Charbonnier Professor of Neurology. He was the Chair of Neurology at Georgetown University (2002-2004), the Melvin Greer Professor of Neurology and Neuroscience at the University of Florida (2004-2008) where he served as Director of Epilepsy Program and Director of the Clinical Alzheimer Research Program, and Professor of Neurology and Pediatrics at Emory University (2008-2013) where he served as Director of Epilepsy and of Clinical Neurocience Research. He joined the faculty of Stanford University in 2013. Dr. Meador has authored over 400 peer-reviewed publications. His research interests include: cognitive mechanisms (e.g., memory and attention); cerebral lateralization; pharmacology and physiology of cognition; mechanisms of perception, consciousness and memory; EEG; epilepsy; epilepsy and pregnancy; preoperative evaluation for epilepsy surgery; intracarotid amobarbital procedure (i.e., Wada test); functional imaging; therapeutic drug trials; neurodevelopmental effects of antiepileptic drugs; psychoimmunology; behavioral disorders (e.g., aphasia, neglect, dementia); and neuropsychiatric disorders. Dr. Meador has served as the PI for a long running NIH multicenter study of pregnancy outcomes in women with epilepsy and their children. Dr. Meador has served on the editorial boards for Clinical Neurophysiology, Epilepsy and Behavior, Epilepsy Currents, Journal of Clinical Neurophysiology, Neurology, Cognitive and Behavioral Neurology, and Epilepsy.com. His honors include Resident Teaching Award Medical College of Georgia; Outstanding Young Faculty Award in Clinical Sciences Medical College of Georgia; Distinguished Faculty Award for Clinical Research Medical College of Georgia Lawrence C. McHenry History Award American Academy of Neurology; Dreifuss Abstract Award American Epilepsy Society; Fellow of the American Neurological Association; Diplomat of American Neurologic Association; past Chair of the Section of Behavioral Neurology of American Academy of Neurology; past President of Society for Cognitive and Behavioral Neurology; past President of the Society for Behavioral & Cognitive Neurology; past President of the Southern EEG & Epilepsy Society; ranking in the top 10 experts in epilepsy worldwide by Expertscape; Distinguished Alumnus Award for Professional Achievement, Medical College of Georgia, Georgia Regents University 2015; American Epilepsy Society Clinical Research Award; and named award by the American Epilepsy Society: “Kimford J. Meador Research in Women with Epilepsy Award,” and ranked in the top 500 neuroscientist in the world and top 300 in USA by Research.com in 2022.
-
Peter Meaney
Clinical Professor, Pediatrics - Critical Care
Current Research and Scholarly InterestsDr. Meaney is a nationally and internationally recognized pediatric resuscitation scientist, and his current focus is on improving care for seriously ill children at the community clinic and district hospital level in low and middle income countries. Dr Meaney seeks to conduct the necessary research to pioneer, implement and evaluate innovative yet relevant and practical solutions to improve the quality of care for seriously ill or injured children worldwide.
-
Bruno Medeiros
Adjunct Clinical Associate Professor, Medicine - Hematology
Current Research and Scholarly InterestsMy clinical activities combine the development of novel therapeutic modalities, translational research activities and epidemiological study of acute leukemia. My special focus is on the development of better, patient tailored therapies for young and elderly patients with acute leukemia.
-
Rishi Mediratta
Clinical Associate Professor, Pediatrics
Current Research and Scholarly InterestsI have developed a new promising neonatal mortality prediction score at the University of Gondar Neonatal Intensive Care Unit (NICU) in Gondar, Ethiopia. The score predicts approximately 84% of neonatal deaths in the NICU using clinical variables. I have a dataset over 800 NICU admissions in Gondar. I am recruiting scholars who are interested in conducting clinical and epidemiological research to validate, refine, and implement the mortality score to reduce neonatal mortality in Ethiopia.
-
Natalia Medvedeva
Clinical Assistant Professor, Medicine - Infectious Diseases
BioDr Natalia Medvedeva specializes in the treatment of infectious diseases. She has a special interest in antimicrobial stewardship and medical education.
-
Uchechukwu Megwalu, MD, MPH
Professor of Otolaryngology - Head & Neck Surgery (OHNS)
Current Research and Scholarly InterestsOutcomes Research
Health Disparities
Comparative Effectiveness Research
Health Literacy
Head and Neck Cancer Epidemiology
SEER database analysis -
Jenny Y. Mei
Clinical Assistant Professor, Obstetrics & Gynecology - Maternal Fetal Medicine
Current Research and Scholarly InterestsPostpartum hypertension
Cardio-obstetrics
Quality improvement -
Kara Meister, MD, FAAP, FACS
Assistant Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Pediatrics
BioKara D. Meister, MD, FAAP, FACS is a pediatric otolaryngologist and head & neck surgeon. She received her medical degree from Medical University of South Carolina and completed her otolaryngology residency at University of Pittsburgh. She completed a NIH-funded fellowship in head and neck research at the University of Pittsburgh. Dr. Meister then went on to complete a pediatric otolaryngology fellowship at Lucile Packard Children’s Hospital Stanford.
She is currently an Assistant Professor in the Department Otolaryngology, Division of Pediatric Otolaryngology, at Stanford University. Dr. Meister’s research interests include thyroid cancer, head & neck masses, Graves' disease. She has a special interest in the influence of the environment and pollutants (such as microplastics) on health. She currently serves as the Associate Clinical Chief of Pediatric Otolaryngology. Dr. Meister completed additional training in innovation through the Stanford Biodesign Faculty Fellowship.
Her clinical interests include the treatment of patients with head and neck masses including thyroid nodules and cancer. She is Co-Director, Surgical, of the Children's Thyroid Center at Lucile Packard Children’s Hospital Stanford and is a participating surgeon in the Aerodigestive and Airway Reconstruction Center at Stanford Children’s Health. She is co-editor of the textbook "Pediatric Bronchoscopy for Clinicians" and enjoys advocacy work with the American Academy of Pediatrics Button Battery Taskforce.
Dr. Meister is a member of the American Thyroid Association (ATA) where she serves on the Diversity, Equity, and Inclusion committee and is a member of the ATA Guidelines Writing Group for Thyroid Disease & Pregnancy. She is a member of the pediatric committee of the American Head and Neck Society. She is an author and speaker on masses and tumors of the head and neck, thyroid disease, and thyroid cancer in children and adolescents. In collaboration with SHC, she offers novel treatment for thyroid problems in children and adolescents including radiofrequency ablation of thyroid nodules.
Dr. Meister lives in Woodside with her husband, 3 children, and Rooney the dog.
Clinical Expertise:
Children's Thyroid Center, Co-Director, Surgical
Thyroid nodules
Thyroid cancer - papillary, follicular, and medullary
Surgical management of hyperthyroidism and Grave's disease
MEN syndrome
Head and Neck masses
Congenital neck masses such as branchial cleft cyst, thyroglossal duct cyst
Pediatric Head and Neck cancer
Airway evaluation and reconstruction, voice and swallowing problems, and Aerodigestive
Fetal Airway and Exit Team -
Bethlehem Mekonnen, MD
Clinical Assistant Professor, Ophthalmology
BioDr. Mekonnen is a board-certified, fellowship-trained ophthalmologist with the Byers Eye Institute at Stanford Health Care. She is also a clinical assistant professor of medicine in the Department of Ophthalmology.
Dr. Mekonnen diagnoses and treats a wide range of eye conditions, including cataracts, corneal and external eye diseases. She creates an individual, comprehensive care plan for each of her patients.
Dr. Mekonnen’s clinical research interests include exploring the most effective medical and surgical therapies for patients with corneal and external eye diseases. She has researched and published on outcomes of macular edema, described a novel surgical technique for severe ocular surface disease and described a possible new ophthalmic manifestation of a rare congenital disorder called Cobb syndrome.
Dr. Mekonnen has published work in the American Journal of Ophthalmology, Cornea: The Journal of Cornea and External Disease, and the Journal of Ophthalmic Inflammation and Infection. She has presented to her peers at the Association for Research in Vision and Ophthalmology, Women in Ophthalmology (WIO) Summer Symposium, and the Annual GlaxoSmithKline Women in Science Conference.
Dr. Mekonnen is a member of the American Academy of Ophthalmology. -
Marc L. Melcher
Professor of Surgery (Abdominal Transplantation)
Current Research and Scholarly InterestsMy goal is to extend the benefits of organ transplantation to greater numbers of patients while maintaining excellent outcomes. We developed the "paired-organ exchange" program at Stanford to increase the chances that patients with willing but incompatible living donors can still receive a living donor kidney. In addition, I am applying artificial intelligence algorithms to facilitate complex decision making in liver transplant.
-
Elizabeth Mellins
Member, Bio-X
Current Research and Scholarly InterestsMolecular mechanisms and intracellular pathways of MHC class II antigen processing and presentation, with a focus on B cells; mechanisms underlying HLA allele association with disease; disease mechanisms in systemic juvenile idiopathic arthritis, including an HLA-linked complication; monocytes as drivers or suppressors of auto-inflammation in systemic juvenile idiopathic arthritis and pediatric acute neuropsychiatric syndrome.
-
Michelle Mello
Professor of Law and of Health Policy
BioMichelle Mello is Professor of Law at Stanford Law School and Professor of Health Policy in the Department of Health Policy at Stanford University School of Medicine. She conducts empirical research into issues at the intersection of law, ethics, and health policy. She is the author of more than 250 articles on medical liability, public health law, the public health response to COVID-19, pharmaceuticals and vaccines, biomedical research ethics and governance, artificial intelligence, health information privacy, and other topics.
The recipient of a number of awards for her research, Dr. Mello was elected to the National Academy of Medicine at the age of 40. From 2000 to 2014, she was a professor at the Harvard School of Public Health, where she directed the School’s Program in Law and Public Health.
Dr. Mello teaches courses in torts and public health law. She holds a J.D. from the Yale Law School, a Ph.D. in Health Policy and Administration from the University of North Carolina at Chapel Hill, an M.Phil. from Oxford University, where she was a Marshall Scholar, and a B.A. from Stanford University. -
Nicholas Melosh
Professor of Materials Science and Engineering
BioThe Melosh group explores how to apply new methods from the semiconductor and self-assembly fields to important problems in biology, materials, and energy. We think about how to rationally design engineered interfaces to enhance communication with biological cells and tissues, or to improve energy conversion and materials synthesis. In particular, we are interested in seamlessly integrating inorganic structures together with biology for improved cell transfection and therapies, and designing new materials, often using diamondoid molecules as building blocks.
My group is very interested in how to design new inorganic structures that will seamless integrate with biological systems to address problems that are not feasible by other means. This involves both fundamental work such as to deeply understand how lipid membranes interact with inorganic surfaces, electrokinetic phenomena in biologically relevant solutions, and applying this knowledge into new device designs. Examples of this include “nanostraw” drug delivery platforms for direct delivery or extraction of material through the cell wall using a biomimetic gap-junction made using nanoscale semiconductor processing techniques. We also engineer materials and structures for neural interfaces and electronics pertinent to highly parallel data acquisition and recording. For instance, we have created inorganic electrodes that mimic the hydrophobic banding of natural transmembrane proteins, allowing them to ‘fuse’ into the cell wall, providing a tight electrical junction for solid-state patch clamping. In addition to significant efforts at engineering surfaces at the molecular level, we also work on ‘bridge’ projects that span between engineering and biological/clinical needs. My long history with nano- and microfabrication techniques and their interactions with biological constructs provide the skills necessary to fabricate and analyze new bio-electronic systems.
Research Interests:
Bio-inorganic Interface
Molecular materials at interfaces
Self-Assembly and Nucleation and Growth -
Fernando S. Mendoza
Associate Dean of Minority Advising and Programs and Professor of Pediatrics (General Pediatrics) at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly InterestsI have two research interests: childhood health disparities and workforce diversity. My research on childhood health disparities centers on Latino and immigrant children with a focus on early childhood health and development. My work in workforce diversity examines the pipeline for diversity in academic pediatrics, with special attention on the pipeline for underrepresent minorities.
-
Joshua Menke
Clinical Assistant Professor, Pathology
BioDr. Joshua Menke completed his hematopathology fellowship at Stanford and a cytopathology fellowship at the University of California, San Francisco (UCSF). His clinical and research interests lie at the intersection of hematopathology, cytopathology, and advanced single-cell and cell-free diagnostic techniques. As the Associate Section Director of Clinical Flow Cytometry at Stanford, Dr. Menke is developing and validating new minimal residual disease assays for detecting low levels of myeloid and lymphoid neoplasms in the post-treatment setting, as well as multiple other 12-color flow assays with the latest markers for routine phenotyping.
Dr. Menke is the recipient of the Paul E. Strandjord Young Investigator Award from the Academy of Clinical Laboratory Scientists and the Laurence J. Marton Award for Excellence in Research from UCSF for his translational work on CALR mutations at the UCSF Molecular Diagnostics Laboratory. Dr. Menke is a founding member of the Cytology-Hematopathology Interinstitutional Collaboration (CHIC), which aims to study the performance of cytology samples in diagnosing lymphoma across large datasets from five academic institutions. He currently chairs this group, leading large clinical research studies. -
Vinod Menon
Rachael L. and Walter F. Nichols, MD, Professor and Professor, by courtesy, of Education and of Neurology and Neurological Sciences
Current Research and Scholarly InterestsEXPERIMENTAL, CLINICAL AND THEORETICAL SYSTEMS NEUROSCIENCE
Cognitive neuroscience; Systems neuroscience; Cognitive development; Psychiatric neuroscience; Functional brain imaging; Dynamical basis of brain function; Nonlinear dynamics of neural systems. -
Antonio Meola, MD, PhD
BioAntonio Meola M.D. Ph.D graduated Summa cum Laude and Research Honors at the University of Pisa, Italy, in 2008, and completed his residency training in Neurosurgery at the same Institution in July 2015. Dr Meola attended a Ph.D. program at the University of Florence, Italy, where he discussed a doctoral thesis entitled "A New Head-Mounted Display-based Augmented Reality System in Neurosurgical Oncology: a study on phantom".
Since 2/2014 to 1/2015 Dr Meola completed a Research Fellowship in Neurosurgical anatomy at the University of Pittsburgh Medical Center (UPMC), under the Direction of Dr. Juan C. Fernandez-Miranda. The main focus of his research was the surgical neuroanatomy of the white matter tracts of the human brain.
Since 7/2015 to 6/2016 Dr Meola served as Clinical Fellow in Image-Guided Neurosurgery at the Brigham and Women's Hospital, Harvard Medical School, in Boston, MA (Director: Dr. Alexandra J. Golby M.D.). During the fellowship, he focused on the clinical application and integration of advanced imaging techniques, including intraoperative-MRI, intraoperative US, functional MRI, tractography.
Since 7/2016 to 6/2017 Dr Meola completed a Neurosurgical Oncology Fellowship at the Cleveland Clinic in Cleveland, OH, devoting his efforts to minimally-invasive neurosurgical techniques, such as Laser interstitial Thermal Therapy (LITT) and stereotactic radiosurgery (Gamma Knife), as well as to awake neurosurgery.
Starting 7/2017, Dr Meola joined the Department of Neurosurgery at Stanford. Dr. Meola mainly focuses on conventional and innovative treatments for brain and skull base tumors, including both surgery and stereotactic radiosurgery (CyberKnife). -
Mark Mercola
Professor of Medicine (Cardiovascular) and, by courtesy, of Chemical and Systems Biology
BioDr. Mercola is Professor of Medicine and Professor in the Stanford Cardiovascular Institute. He completed postdoctoral training at the Dana-Farber Cancer Institute and Harvard Medical School, was on the faculty in the Department of Cell Biology at Harvard Medical School for 12 years, and later at the Sanford-Burnham-Prebys Institute and Department of Bioengineering at the University of California, San Diego before relocating to Stanford in 2015.
Prof. Mercola is known for identifying many of the factors that are responsible for inducing and forming the heart, including the discovery that Wnt inhibition is a critical step in cardiogenesis that provided the conceptual basis and reagents for the large-scale production of cardiovascular tissues from pluripotent stem cells. He has collaborated with medicinal chemists, optical engineers and software developers to pioneer the use of patient iPSC-cardiomyocytes for disease modeling, safety pharmacology and drug development. His academic research is focused on developing and using quantitative high throughput assays of patient-specific cardiomyocyte function to discover druggable targets for preserving contractile function in heart failure and promoting regeneration following ischemic injury. He co-established drug screening and assay development at the Conrad Prebys Drug Discovery Center (San Diego), which operated as one of 4 large screening centers of the US National Institutes of Health (NIH) Molecular Libraries screening initiative and continues as one of the largest academic drug screening centers.
Prof. Mercola received an NIH MERIT award for his work on heart formation. He holds numerous patents, including describing the invention of the first engineered dominant negative protein and small molecules for stem cell and cancer applications. He serves on multiple editorial and advisory boards, including Vala Sciences, Regencor, The Ted Rogers Centre for Heart Research and the Human Biomolecular Research Institute. His laboratory is funded by the National Institutes of Health (NIH), California Institute for Regenerative Medicine, Phospholamban Foundation and Fondation Leducq. -
Thomas Charles Merigan M.D.
George E. and Lucy Becker Professor of Medicine, Emeritus
Current Research and Scholarly InterestsI am now emeritus and only participate in university activities through advising my former trainees who have joined the faculty.
-
Anna H. Messner, MD
Professor of Otolaryngology-Head and Neck Surgery (Pediatrics) at the Stanford University Medical Center and the Lucile Salter Packard Children's Hospital, Emerita
Current Research and Scholarly Interests-- Obstructive sleep apnea in children
-- Postoperative tonsillectomy care
-- Ankyloglossia
-- Medical Education -
Everett Meyer
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy), of Pediatrics (Stem Cell Transplantation) and, by courtesy, of Surgery (Abdominal Transplantation)
Current Research and Scholarly InterestsResearch focus in T cell immunotherapy and T cell immune monitoring using high-throughput sequencing and genomic approaches, with an emphasis on hematopoietic stem cell transplantation, the treatment of graft-versus-host disease and immune tolerance induction.
-
Timothy Meyer
Stanford University Professor of Nephrology, Emeritus
Current Research and Scholarly InterestsInadequate removal of uremic solutes contributes to widespread illness in the more than 500,000 Americans maintained on dialysis. But we know remarkably little about these solutes. Dr. Meyer's research efforts are focused on identifying which uremic solutes are toxic, how these solutes are made, and how their production could be decreased or their removal could be increased. We should be able to improve treatment if we knew more about what we are trying to remove.
